Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother. 2017;72:i39-47.

Article  CAS  PubMed  Google Scholar 

Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–92.

Article  PubMed  Google Scholar 

Taccone FS, Van den Abeele A-M, Bulpa P, Misset B, Meersseman W, Cardoso T, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19:7.

Article  PubMed  PubMed Central  Google Scholar 

Karthaus M, Buchheidt D. Invasive aspergillosis: new insights into disease, diagnostic and treatment. Curr Pharm Des. 2013;19:3569–94.

Article  CAS  PubMed  Google Scholar 

Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg. 2004;59:251–7.

Article  CAS  PubMed  Google Scholar 

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71:1367–76.

Article  PubMed  Google Scholar 

Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621–5.

Article  PubMed  Google Scholar 

Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007;33:1694–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blot SI, Van den Taccone FS, Bulpa P, Meersseman W, Brusselaers N, et al. AspICU study investigators. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186:56–64.

Article  PubMed  Google Scholar 

Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med. 2001;27:59–67.

Article  CAS  PubMed  Google Scholar 

Leistner R, Schroeter L, Adam T, Poddubnyy D, Stegemann M, Siegmund B, et al. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients. Crit Care. 2022;26:30.

Article  PubMed  PubMed Central  Google Scholar 

Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, et al. Risk factors for invasive aspergillosis in ICU-hospitalized patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021;11:136.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dellière S, Dudoignon E, Fodil S, Voicu S, Magalie Collet P-AO, et al. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU-hospitalized patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2020;27:790.e1-790.e5.

Article  PubMed  Google Scholar 

Vallés J, Mesalles E, Mariscal D, del Mar Fernández M, Peña R, Jiménez JL, et al. A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med. 2003;29:1981–8.

Article  PubMed  Google Scholar 

Verweij PE, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Buil JB, et al. Taskforce report on the diagnosis and clinical management of COVID-19-associated pulmonary aspergillosis. Intensive Care Med. 2021;47:819.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-67.

Article  PubMed  PubMed Central  Google Scholar 

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61–111.

Article  PubMed  PubMed Central  Google Scholar 

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.

Article  CAS  PubMed  Google Scholar 

Torres A, Martin-Loeches I. Invasive pulmonary aspergillosis in ventilator-associated pneumonia: the hidden enemy? Am J Respir Crit Care Med. 2020;202:1071–3.

Article  PubMed  PubMed Central  Google Scholar 

Townsend L, Martin-Loeches I. Invasive aspergillosis in the intensive care unit. Diagnostics (Basel). 2022;12:2712.

Article  CAS  PubMed  Google Scholar 

Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010;14:R167.

Article  PubMed  PubMed Central  Google Scholar 

Kamai Y, Chiang L, Lopes Bezerra L, Doedt T, Lossinsky A, Sheppard D, et al. Interactions of aspergillus fumigatus with vascular endothelial cells. Med Mycol. 2006;44:S115-117.

Article  PubMed  Google Scholar 

Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis. 2014;27:174–83.

Article  CAS  PubMed  Google Scholar 

Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care. 2006;10:R31.

Article  PubMed  PubMed Central  Google Scholar 

Martin-Loeches I, Schultz J, Vincent M, Alvarez-Lerma JL, Bos F, Solé-Violán LD. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43:48–58.

Article  PubMed  Google Scholar 

Shi C, Shan Q, Xia J, Wang L, Wang L, Qiu L, et al. Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: a systematic review and meta-analysis. Mycoses. 2022;65:152–63.

Article  PubMed  Google Scholar 

Ku YH, Chan KS, Yang CC, Tan CK, Chuang YC, Yu WL. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections. J Formos Med Assoc. 2017;116:660–70.

Article  PubMed  Google Scholar 

Schroeder M, Simon M, Katchanov J, Wijaya C, Rohde H, Christner M, et al. Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study. Crit Care. 2016;20:139.

Article  PubMed  PubMed Central  Google Scholar 

D’Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, Lammertijn L, et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol. 2012;50:1258–63.

Article  PubMed  PubMed Central  Google Scholar 

He Q, Yuwen R, Hongxing L, Lulu L, Binchan H, Yi S, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66:261–7.

Article  CAS  PubMed  Google Scholar 

Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect. 2005;11:427–9.